Shaw Christine 4
4 · GenMark Diagnostics, Inc. · Filed Mar 1, 2021
Insider Transaction Report
Form 4
Shaw Christine
VP, Assay Development
Transactions
- Sale
Common Stock
2021-02-26$17.03/sh−3,151$53,662→ 102,470 total
Footnotes (1)
- [F1]The shares were sold pursuant to pre-established trading instructions solely to satisfy tax withholding obligations in connection with the partial vesting of previously granted restricted stock units.